Save time and get answers to complex questions with AI chat
What are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Fda livtencity approval letter march 23 2021 regulatory project managerWhen does the patent expire on ibranceAdefovir dipivoxil discount card
See the DrugPatentWatch profile for yervoy
Yervoy (ipilimumab) is a brand-name biologic (an antibody), so its “patent life” depends on which specific patent(s) and exclusivities you mean (US vs. Europe, primary composition vs. formulation vs. method-of-use, etc.).
In the United States, the principal biologic exclusivity for Yervoy began after FDA approval in 2011, and the earliest expected expiration of exclusivity is generally cited as 2021. However, actual market exclusivity/patent protection can extend beyond that due to additional, separate patents and follow-on exclusivities (and biosimilar approval pathways).
If you tell me which country (US/Europe/etc.) and whether you mean patent expiration vs. biologic exclusivity vs. biosimilar launch eligibility, I can give you a more precise answer.
Other Questions About Yervoy :